- Home
- ASB vs AXSM Comparison
ASB vs AXSM Comparison
Compare ASB & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASB
- AXSM
- Stock Information
- Founded
- ASB 1861
- AXSM 2012
- Country
- ASB United States
- AXSM United States
- Employees
- ASB N/A
- AXSM N/A
- Industry
- ASB Major Banks
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- ASB Finance
- AXSM Health Care
- Exchange
- ASB Nasdaq
- AXSM Nasdaq
- Market Cap
- ASB 4.4B
- AXSM 5.1B
- IPO Year
- ASB N/A
- AXSM 2015
- Fundamental
- Price
- ASB $25.95
- AXSM $116.62
- Analyst Decision
- ASB Hold
- AXSM Strong Buy
- Analyst Count
- ASB 11
- AXSM 17
- Target Price
- ASB $27.64
- AXSM $175.76
- AVG Volume (30 Days)
- ASB 1.2M
- AXSM 576.1K
- Earning Date
- ASB 10-23-2025
- AXSM 11-11-2025
- Dividend Yield
- ASB 3.59%
- AXSM N/A
- EPS Growth
- ASB N/A
- AXSM N/A
- EPS
- ASB 0.78
- AXSM N/A
- Revenue
- ASB $1,035,964,000.00
- AXSM $495,033,000.00
- Revenue This Year
- ASB $56.79
- AXSM $63.78
- Revenue Next Year
- ASB $5.69
- AXSM $55.74
- P/E Ratio
- ASB $32.69
- AXSM N/A
- Revenue Growth
- ASB 3.82
- AXSM 69.83
- 52 Week Low
- ASB $18.32
- AXSM $75.56
- 52 Week High
- ASB $28.18
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- ASB 50.07
- AXSM 48.36
- Support Level
- ASB $25.34
- AXSM $112.90
- Resistance Level
- ASB $26.50
- AXSM $130.00
- Average True Range (ATR)
- ASB 0.54
- AXSM 3.70
- MACD
- ASB -0.13
- AXSM -1.47
- Stochastic Oscillator
- ASB 28.54
- AXSM 21.75
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.